Of the 10 studies evaluating BCMA expression in lymphoma, six studies assessed patients with non-Hodgkin lymphoma (NHL)24,28,31–34, one study assessed patients with Hodgkin lymphoma (HL)35, and three studies assessed a mixed NHL and HL population10,14,21. The gene discussed is TNFRSF17; the disease is Hodgkins lymphoma.